# CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 Q2 P&L / Income Statement

- Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Period: 2026-03-29 to 2026-06-27
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001100682-26-000118
- Page: https://plicit.ai/financials/crl/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/crl-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-03-29 through 2026-06-27. View: Product and service. Revenue and costs use their disclosed categories.

- **Total revenue**: 1,004,078,000 US dollars
- **Cost of revenue (calculated)**: 640,704,000 US dollars
- **Gross profit (calculated)**: 363,374,000 US dollars
- **Operating expenses (calculated)**: 243,486,000 US dollars
- **Operating income**: 119,888,000 US dollars
- **Other income (expense), net (calculated)**: negative 66,718,000 US dollars
- **Income before income taxes**: 53,170,000 US dollars
- **Provision for income taxes**: 53,930,000 US dollars
- **Net income (loss)**: negative 760,000 US dollars
- **Service revenue**: 808,287,000 US dollars
- **Product revenue**: 195,791,000 US dollars
- **Service cost of revenue**: 552,007,000 US dollars
- **Product cost of revenue**: 88,697,000 US dollars
- **Amortization of intangible assets**: 14,589,000 US dollars
- **Selling, general and administrative**: 228,897,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$1.48 M; to noncontrolling interests: $722.00 K.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/crl/fy2026-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/crl-fy2026-q2-revenue-by-business-segment-sankey.png

Income statement for 2026-03-29 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 1,004,078,000 US dollars
- **Cost of revenue (calculated)**: 640,704,000 US dollars
- **Gross profit (calculated)**: 363,374,000 US dollars
- **Operating expenses (calculated)**: 243,486,000 US dollars
- **Operating income**: 119,888,000 US dollars
- **Other income (expense), net (calculated)**: negative 66,718,000 US dollars
- **Income before income taxes**: 53,170,000 US dollars
- **Provision for income taxes**: 53,930,000 US dollars
- **Net income (loss)**: negative 760,000 US dollars
- **Research Models and Services Segment**: 209,475,000 US dollars
- **Discovery and Safety Assessment Segment**: 606,507,000 US dollars
- **Manufacturing**: 188,096,000 US dollars
- **Cost of revenue (excluding amortization of intangible assets)**: 640,704,000 US dollars
- **Amortization of intangible assets**: 14,589,000 US dollars
- **Selling, general and administrative**: 228,897,000 US dollars
- **Research Models and Services Segment costs (calculated)**: 173,198,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Discovery and Safety Assessment Segment costs (calculated)**: 482,108,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Manufacturing costs (calculated)**: 122,490,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 106,394,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$1.48 M; to noncontrolling interests: $722.00 K.

## Chart details: Revenue by Business Segment by Timing of Transfer

- Page: https://plicit.ai/financials/crl/fy2026-q2-income-statement/revenue-by-business-segment-by-timing-of-transfer
- Chart image: https://plicit.ai/charts/crl-fy2026-q2-revenue-by-business-segment-by-timing-of-transfer-sankey.png

Income statement for 2026-03-29 through 2026-06-27. View: Segments by Timing of Transfer of Good or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 1,004,078,000 US dollars
- **Cost of revenue (calculated)**: 640,704,000 US dollars
- **Gross profit (calculated)**: 363,374,000 US dollars
- **Operating expenses (calculated)**: 243,486,000 US dollars
- **Operating income**: 119,888,000 US dollars
- **Other income (expense), net (calculated)**: negative 66,718,000 US dollars
- **Income before income taxes**: 53,170,000 US dollars
- **Provision for income taxes**: 53,930,000 US dollars
- **Net income (loss)**: negative 760,000 US dollars
- **Discovery and Safety Assessment Segment - Services and products transferred at a point in time**: 572,000 US dollars
- **Discovery and Safety Assessment Segment - Services and products transferred over time**: 605,935,000 US dollars
- **Manufacturing - Services and products transferred at a point in time**: 103,192,000 US dollars
- **Manufacturing - Services and products transferred over time**: 84,904,000 US dollars
- **Research Models and Services Segment - Services and products transferred at a point in time**: 115,105,000 US dollars
- **Research Models and Services Segment - Services and products transferred over time**: 94,370,000 US dollars
- **Cost of revenue (excluding amortization of intangible assets)**: 640,704,000 US dollars
- **Amortization of intangible assets**: 14,589,000 US dollars
- **Selling, general and administrative**: 228,897,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$1.48 M; to noncontrolling interests: $722.00 K.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/crl/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/crl-fy2026-q2-revenue-by-geography-sankey.png

Income statement for 2026-03-29 through 2026-06-27. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 1,004,078,000 US dollars
- **Cost of revenue (calculated)**: 640,704,000 US dollars
- **Gross profit (calculated)**: 363,374,000 US dollars
- **Operating expenses (calculated)**: 243,486,000 US dollars
- **Operating income**: 119,888,000 US dollars
- **Other income (expense), net (calculated)**: negative 66,718,000 US dollars
- **Income before income taxes**: 53,170,000 US dollars
- **Provision for income taxes**: 53,930,000 US dollars
- **Net income (loss)**: negative 760,000 US dollars
- **UNITED STATES**: 539,861,000 US dollars
- **Europe**: 263,074,000 US dollars
- **CANADA**: 127,508,000 US dollars
- **Asia Pacific**: 60,517,000 US dollars
- **Other**: 13,118,000 US dollars
- **Cost of revenue (excluding amortization of intangible assets)**: 640,704,000 US dollars
- **Amortization of intangible assets**: 14,589,000 US dollars
- **Selling, general and administrative**: 228,897,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$1.48 M; to noncontrolling interests: $722.00 K.
